GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CARETEQ CTQ.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.01

0.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$6.1m

FY2020FY2026

Net income

−A$398,121

FY2020FY2026

Free cash flow

−A$1.6m

FY2020FY2026

Shareholders' equity

A$3.2m

FY2020FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
RevenueA$6.1mA$7.6mA$7.2mA$5.0mA$4.4mA$735,442A$146,458
Research and development——A$74,225A$104,800A$29,211A$8,356A$20,811
Operating income−A$274,738A$225,832−A$520,271−A$2.6m−A$2.9m−A$2.6m−A$2.0m
Net income−A$398,121−A$72,204−A$2.7m−A$4.3m−A$5.3m−A$5.2m−A$1.9m
Diluted earnings per share-0.00-0.00-0.01-0.03-0.04-0.04-0.01

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Total assetsA$3.8mA$5.9mA$6.8mA$7.6mA$8.0mA$12.2mA$926,867
Cash and short-term investmentsA$3.2mA$1.0mA$1.3mA$1.9mA$4.5mA$8.9mA$202,047
Total liabilitiesA$549,166A$4.4mA$3.3mA$4.0mA$1.7mA$2.6mA$4.7m
DebtA$47,563A$2.4mA$192,978A$961,960—A$75,281—
Shareholders' equityA$3.2mA$1.5mA$2.0mA$2.1mA$6.3mA$9.6m−A$3.7m
Shares outstanding319m237m217m133m142m142m142m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−A$1.5m−A$732,058−A$1.3m−A$2.5m−A$4.2m−A$1.5m−A$1.3m
Capital spending−A$63,690−A$72,875−A$1.3m−A$883,950−A$16,956−A$23,209−A$11,554
Free cash flow−A$1.6m−A$804,933−A$2.6m−A$3.4m−A$4.3m−A$1.5m−A$1.3m
Dividends paid—−A$90,000−A$112,500————

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Sept 2023Jun 2023
RevenueA$6.0mA$51,003A$3.6mA$4.0mA$3.1mA$4.2mA$2.3mA$3.1m
Operating incomeA$452,854−A$727,592−A$197,592A$423,424−A$819,650−A$412,220−A$310,423−A$1.7m
Net incomeA$524,066−A$277,931A$77,948−A$150,152−A$751,315−A$1.1m−A$571,386−A$1.9m
Diluted earnings per share0.00-0.000.00-0.00-0.00-0.01-0.00-0.01
Cash from operations−A$1.0m————−A$1.0m—−A$1.0m
Capital spending————−A$1.0m———
Total assetsA$3.8mA$4.4mA$5.9mA$5.7mA$6.8mA$9.3mA$9.3mA$7.6m
Cash and short-term investmentsA$3.2mA$681,802A$1.0mA$846,733A$1.3mA$2.2mA$2.2mA$1.9m
DebtA$47,563A$2.3mA$1.8mA$2.3mA$192,977A$928,776A$700,000A$961,960
Shareholders' equityA$3.2mA$1.2mA$1.5mA$942,682A$2.0mA$3.6mA$3.6mA$2.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue6.9%52.6%—
Operating income-52.4%-36.1%—
Net income-54.9%-40.3%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-0.4%-12.1%-27.8%—
Net margin-3.4%-28.8%-57.7%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022
Price to earnings-8.0-36.1-0.8-0.9-1.5
Price to sales0.50.30.30.81.8

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.